(64 days)
Not Found
No
The summary describes a silicone sheet for scar treatment and contains no mention of AI, ML, or related concepts like image processing or performance metrics typically associated with AI/ML devices.
Yes
The device is intended for "treating thick painful, itchy, red and raised hypertrophic or keloid scars," which is a therapeutic purpose.
No
The device is described as a treatment for scars, not for identifying or diagnosing a medical condition.
No
The device description explicitly states it is a "thin soft silicone sheet," which is a physical hardware component, not software.
Based on the provided information, the Sil-K device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for treating scars, which is a therapeutic application on the body.
- Device Description: The device is a silicone sheet applied externally to the skin.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
IVD devices are specifically designed to be used in vitro (outside the body) to analyze biological samples. The Sil-K device is used in vivo (on the body) for treatment.
N/A
Intended Use / Indications for Use
The Sil-K is designed and indicated for treating thick painful, itchy, red and raised hypertrophic or keloid scars.
Product codes
MDA
Device Description
Sil-K is a thin soft silicone sheet used to treat thick painful, itchy, red and raised hypertrophic or keloid scars. Sil-K is designed to be used only after the skin has completely healed and is non invasive.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4025 Silicone sheeting.
(a)
Identification. Silicone sheeting is intended for use in the management of closed hyperproliferative (hypertrophic and keloid) scars.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 878.9.
0
Image /page/0/Picture/0 description: The image shows a circular logo with the text "ISO 9001" in the center. The logo is surrounded by the text "Standardization of Israel". The image is black and white and appears to be a scan or photocopy. The logo is slightly distorted and the text is not perfectly clear.
Image /page/0/Picture/1 description: The image shows the words "Degania Silicone" in a bold, sans-serif font. The word "Degania" is in black, while the word "Silicone" is in white with a black outline. The words are next to each other, with "Degania" on the left and "Silicone" on the right.
JUN 2 4 1997
Degania Silicone Ltd. Degania Bet 15130, Israel. Tel: 972-6-755712, Fax: 972-6-709182
TÜV
APPENDIX E
~
510 (k) SUMMARY
Trade Name: Degania Silicone Sil-K
Common Name: Silicone Elastomer Sheet
Device Class: Unclassified
Classification Panel: General & Restorative Devices
Establishment Registration Number: 8030107
This summary of 510K safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 JER 807:92.
DEVICE DESCRIPTION AND USE:
Sil-K is a thin soft silicone sheet used to treat thick painful, itchy, red and raised hypertrophic or keloid scars.
Sil-K is designed to be used only after the skin has completely healed and is non invasive.
MANUFACTURING:
The Sil-K is manufactured from the same raw materials, from the same vendors and using the same manufacturing processes as our previous 510(k).
SUBSTANTIAL EQUIVALENCE:
We are Substantially Equivalent to ourselves.
selta
Bette Lubin Product Advisor & Regulatory Affairs Degania Silicone
16 april 1997
Date
2 Y/29
1
Image /page/1/Picture/1 description: The image shows a circular seal with text around the perimeter and a symbol in the center. The text reads "DEPARTMENT OF HEALTH & HUM. SERVICES - USA". The symbol in the center appears to be three stylized human profiles facing right, with flowing lines beneath them.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 2 4 1997
Ms. Bette Lubin Product Advisor & Regulatory Affairs Degania Silicone Ltd. ························································································································································ Degania Bet 15130 Israel
Re: K971482 Trade Name: Degania Silicone Sil-K Regulatory Class: Unclassified Product Code: MDA Dated: April 16, 1997 Received: April 21, 1997
Dear Ms. Lubin:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements , as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
2
Page 2 - Ms. Bette Lubin
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. ……
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten. P.
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Image /page/3/Picture/0 description: The image shows the words "Degania Silicone" in a split-screen format. The word "Degania" is in white letters on a black background, while the word "Silicone" is in black outline letters on a white background. The two words are side-by-side, creating a visually contrasting effect.
Image /page/3/Picture/1 description: The image shows a black and white seal with the text "ISO 9002" in the center. The text "The Standards Institution of Israel" is written around the circle. The seal appears to be stamped or printed, as the edges are not perfectly clean and there are some smudges around the perimeter.
ាប់ (
Degania Silicone Ltd. Degania Bet 15130, Israel. Tel: 972-6-755712, Fax: 972-6-709182
长971482
~
INDICATIONS FOR USE
Device Name: Degania Silicone Sil-K
Indications For Use: The Sil-K is designed and indicated for treating thick painful, itchy, red and raised hypertrophic or keloid scars.
Degania Silicone Ltd. is submitting a new Premarket Notification begania birreone noa. It banketery of the previous 510(k) number is K 914701.
Orvision Sign-Off) Division of General Restorative Devices K971482 510(k) Number _
FLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE
Concurrence of CDRH. Office of Device Evaluation (ODE)
or
Prescription Use: (Fer 21 CFR 801:109) Over-The-Counter :
(Optional Format 1-2-96)